Refractory post-thymectomy myasthenia gravis with onset at MGFA stage V: a case report
- PMID: 35551621
- PMCID: PMC9097348
- DOI: 10.1186/s13019-022-01872-0
Refractory post-thymectomy myasthenia gravis with onset at MGFA stage V: a case report
Abstract
Background: Post-thymectomy myasthenia gravis (PTMG) is defined as thymoma patients without signs of myasthenia gravis (MG) pre-operation, but develop MG after radical surgical resection. PTMG might be misdiagnosed not only because of its rare incidence, but also the uncertain interval between the removal of thymoma and the new onset MG. Additionally, some surgeons and anesthesiologists pay less attention to those asymptomatic thymoma patients in perioperative management, leading to the neglect of new onset PTMG, and miss the best time to treat it.
Case presentation: Majority of cases of PTMG with onset at stage I-II on the basis of Myasthenia Gravis Foundation of America (MGFA) classification have been reported, but rarely at stage V, which requiring intubation or non-invasive ventilation to avoid intubation. Herein, we presented a 70-year-old male with PTMG onset at MGFA stage V, meanwhile, he had severe pulmonary infection interfering with the diagnosis of PTMG, and eventually progressed to refractory PTMG, which requiring much more expensive treatments and longer hospital stays.
Conclusion: In the perioperative management of asymptomatic thymoma patients, careful preoperative evaluation including physical examination, electrophysiological test and acetylcholine receptor antibodies (AChR-Ab) level should be done to identify subclinical MG. Complete resection should be performed during thymectomy, if not, additional postoperative adjuvant therapy is neccessary to avoid recurrence. It's important to identify PTMG at a early stage, especially when being interfered with by postoperative complications, such as lung infection, so that treatments could be initiated as soon as possible to avoid developing to refractory PTMG.
Keywords: Case report; Infection; Misdiagnose; Post-thymectomy myasthenia gravis; Thymoma.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interest.
Similar articles
-
Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV-V) generalized myasthenia gravis: is the game really worth the candle?Eur J Cardiothorac Surg. 2023 May 2;63(5):ezad179. doi: 10.1093/ejcts/ezad179. Eur J Cardiothorac Surg. 2023. PMID: 37162377
-
Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):222-227. doi: 10.1053/j.semtcvs.2018.02.027. Epub 2018 Mar 6. Semin Thorac Cardiovasc Surg. 2018. PMID: 29522809
-
Thymoma pathology and myasthenia gravis outcomes.Muscle Nerve. 2021 Jun;63(6):868-873. doi: 10.1002/mus.27220. Epub 2021 Mar 16. Muscle Nerve. 2021. PMID: 33675078
-
Myasthenia Gravis and Thymoma Surgery: A Clinical Update for the Cardiothoracic Anesthesiologist.J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2537-2545. doi: 10.1053/j.jvca.2018.07.036. Epub 2018 Jul 29. J Cardiothorac Vasc Anesth. 2019. PMID: 30219643 Review.
-
Robotic thymectomy for myasthenia gravis.Thorac Surg Clin. 2014 May;24(2):189-95, vi-vii. doi: 10.1016/j.thorsurg.2014.02.012. Thorac Surg Clin. 2014. PMID: 24780423 Review.
Cited by
-
Sequential development of diffuse panbronchiolitis and myasthenia gravis after thymectomy for thymic neoplasm: a case report.BMC Pulm Med. 2024 Jul 2;24(1):310. doi: 10.1186/s12890-024-03134-2. BMC Pulm Med. 2024. PMID: 38956567 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical